Stevanato Group SpA (STVN) - Cash Flow Conversion Efficiency
Based on the latest financial reports, Stevanato Group SpA (STVN) has a cash flow conversion efficiency ratio of 0.021x as of June 2026. Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow ($31.86 Million) by net assets ($1.55 Billion). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations. Also see how much is Stevanato Group SpA worth for the company's overall valuation and market capitalisation.
Stevanato Group SpA - Cash Flow Conversion Efficiency Trend (2019–2025)
This chart illustrates how Stevanato Group SpA's cash flow conversion efficiency has evolved over time, based on yearly financial data.
Stevanato Group SpA Competitors by Cash Flow Conversion Efficiency
The table below lists competitors of Stevanato Group SpA ranked by their cash flow conversion efficiency. Explore STVN operating cash flow to net income to measure how well operating cash flow supports reported net income.
| Company | Cash Flow Conversion Efficiency |
|---|---|
|
Virtus Investment Partners, Inc.
NASDAQ:VRTS
|
0.106x |
|
MAC Copper Ltd
AU:MAC
|
0.243x |
|
Capitol Federal Financial Inc
NASDAQ:CFFN
|
0.017x |
|
Shaanxi Heimao Coking Co Ltd
SHG:601015
|
0.086x |
|
NanJi ECommerce Co Ltd
SHE:002127
|
0.029x |
|
Shinva Medical Instrument Co Ltd
SHG:600587
|
-0.003x |
|
NPK International Inc.
NYSE:NPKI
|
0.059x |
|
Arcadyan Technology Corp
TW:3596
|
-0.503x |
Annual Cash Flow Conversion Efficiency for Stevanato Group SpA (2019–2025)
The table below shows the annual cash flow conversion efficiency of Stevanato Group SpA from 2019 to 2025. View Stevanato Group SpA stock price for real-time trading data and today's change.
| Year | Net Assets | Operating Cash Flow | Cash Flow Conversion Efficiency | Change |
|---|---|---|---|---|
| 2025-12-31 | $1.49 Billion | $274.79 Million | 0.185x | +66.71% |
| 2024-12-31 | $1.40 Billion | $155.78 Million | 0.111x | +19.41% |
| 2023-12-31 | $1.13 Billion | $105.21 Million | 0.093x | -10.45% |
| 2022-12-31 | $995.91 Million | $103.30 Million | 0.104x | -34.51% |
| 2021-12-31 | $841.66 Million | $133.30 Million | 0.158x | -68.44% |
| 2020-12-31 | $310.14 Million | $155.66 Million | 0.502x | +212.93% |
| 2019-12-31 | $265.44 Million | $42.57 Million | 0.160x | -- |
About Stevanato Group SpA
Stevanato Group S.p.A. engages in the design, production, and distribution of products and processes to provide solutions for biopharma and healthcare industries in Europe, the Middle East, Africa, North America, South America, and the Asia Pacific. It operates through two segments, Biopharmaceutical and Diagnostic Solutions; and Engineering. The company offers drug containment solutions comprisi… Read more